Latest immune evasion News

Stress-linked gut viruses may help tumors evade immune system
Immunology center announces 2026 multidisciplinary seed grant recipients
George Coukos appointed director of new Ludwig Laboratory for Cell Therapy
Over SEK 90 million awarded to OnkPat researchers by the Swedish Cancer Society
Ovarian tumor immune landscapes offer clues to better therapy
XFG could become the next dominant COVID variant. Here’s what to know about ‘Stratus’
The virus that won’t quit: New research reveals how SARS-CoV-2 evolves
Leader cells key to stopping ovarian cancer’s double impact
Virtual screening IDs potential small molecule drugs for cancer immunotherapy
AI-powered Pipeline For Personalized Cancer Vaccines
Parasite In Nucleus
Avian flu has infected dairy cows in more than a dozen states – a microbiologist explains how the virus is spreading
COVID: why the UK’s autumn vaccine strategy could fail patients
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Analysis of brain tumor blood vessels yields a candidate therapy-and a platform to find more
Research reveals how disordered proteins contribute to the properties of the rabies virus
Research brings better understanding of how disordered proteins contribute to the properties of the rabies virus
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
International collaboration to fund breakthrough research to shape the future of precision medicine
Griffith unlocking secrets to Strep virulence
Ludwig Cancer Research study uncovers novel aspect of tumor evolution and potential targets for therapy
Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
First Omicron-adapted Covid boosters are coming
ATAGI update following weekly Covid meeting 19 July